Adcirca and Enteritis infectious - a phase IV clinical study of FDA data

Summary:

Enteritis infectious is reported as a side effect among people who take Adcirca (tadalafil), especially for people who are female, 50-59 old, also take Opsumit, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Enteritis infectious when taking Adcirca. It is created by eHealthMe based on reports of 54,899 people who have side effects when taking Adcirca from the FDA, and is updated regularly.

What is Adcirca?

Adcirca has active ingredients of tadalafil. It is often used in pulmonary hypertension. eHealthMe is studying from 54,957 Adcirca users. Check the latest studies of Adcirca.

What is Enteritis infectious?

Enteritis infectious (infection with feline parvovirus (fpv), also known as feline panleucopenia virus) is found to be associated with 365 drugs and 416 conditions by eHealthMe. Check the latest studies of Enteritis infectious.

On Jul, 18, 2026

54,899 people reported to have side effects when taking Adcirca.
Among them, 21 people (0.04%) have Enteritis infectious.

Could Adcirca cause Enteritis infectious?

Among these 21 people:

What is the gender of people who have Enteritis infectious when taking Adcirca? *

female: 90.48 %
male: 9.52 %

What is the age of people who have Enteritis infectious when taking Adcirca? *

What are other drugs people take besides Adcirca? *

What are other side effects people have besides Enteritis infectious? *

Diarrhea: 12 people, 57.14%
Headache (pain in head): 10 people, 47.62%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 9 people, 42.86%
Hypotension (abnormally low blood pressure): 8 people, 38.10%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 28.57%
Death: 5 people, 23.81%
Abdominal Pain: 2 people, 9.52%
Toothaches (tooth pain): 2 people, 9.52%
Anaemia (lack of blood): 2 people, 9.52%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 9.52%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 11 people, 52.38%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 8 people, 38.10%
High Blood Pressure: 8 people, 38.10%
Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 8 people, 38.10%
Autoimmune Hepatitis: 8 people, 38.10%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 8 people, 38.10%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 8 people, 38.10%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 9.52%
Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 1 person, 4.76%
Right Ventricular Failure (right half of the heart fails to work): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Adcirca and have Enteritis infectious?

- Check whether Enteritis infectious is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Adcirca:

Adcirca (54,957 reports)

Browse all side effects of Adcirca:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Enteritis infectious:

Enteritis infectious (365 drugs)

Browse all the conditions that are associated with Enteritis infectious:

Enteritis infectious (416 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tadalafil (the active ingredients of Adcirca) and Adcirca (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.